Feb 3, 2025 · A recent study found that combined tocilizumab and glucocorticoid therapy for at least 6 months did not fully eliminate vascular inflammation in patients with giant cell arteritis.

Giant cell arteritis is a systemic vasculitis and careful attention should be given to the examination of the cardiovascular system including performing blood pressure measurements in both arms.

Jul 25, 2024 · Patients with giant cell arteritis (GCA) also struggle to taper or stop using GCs. For these patients, the IL-6 receptor alpha inhibitor tocilizumab has demonstrated benefits in …

Mar 25, 2025 · A study involving patients with polymyalgia rheumatica or giant cell arteritis found a 1.9% prevalence of glucocorticoid therapy–induced adrenal insufficiency following the …

Jun 14, 2024 · Results from the SELECT-GCA study showed upadacitinib (Rinvoq) induced significant and sustained remission in people with new-onset or relapsing giant cell arteritis.

Polymyalgia rheumatica and giant cell arteritis are related autoimmune conditions that occur primarily in older adults. This review highlights recent advances in their diagnosis and …

Aug 29, 2024 · Exposure to high levels of particulate matter with diameter ≤ 10 μm was associated with an increased risk for giant cell arteritis but not ischemic complications, an …

Oct 2, 2002 · If this is giant-cell arteritis (GCA), what other treatment options would you recommend? Is it important to normalize the ESR completely without ongoing symptoms?

May 13, 2024 · In a prospective study, all patients diagnosed with giant cell arteritis using ultrasound maintained their diagnosis for up to 2 years of follow-up.

May 7, 2014 · The patient was diagnosed as having polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) and started on 60 mg prednisone 4 days after the onset of symptoms, with …